EyePoint Pharmaceuticals (EYPT) Misses Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts EYPT Hot Sheet
Join SI Premium – FREE
EyePoint Pharmaceuticals (NASDAQ: EYPT) reported Q4 EPS of ($0.81), $0.06 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $620 thousand versus the consensus estimate of $1.05 million.
For earnings history and earnings-related data on EyePoint Pharmaceuticals (EYPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance
- Trump: US Will Be Taking Kharg Island
- Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
